Boundless Bio (BOLD) director receives grant of 32,000 stock options at $1.40
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Boundless Bio director Nancy Whiting received a grant of stock options for 32,000 shares of Common Stock at an exercise price of $1.40 per share. The options vest in substantially equal monthly installments over 12 months after June 15, 2026, or in full at the next annual stockholder meeting before June 15, 2027, if earlier, contingent on continued board service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Whiting Nancy
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 32,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 32,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 32,000 shares
Exercise price: $1.40 per share
Shares after transaction: 32,000 options
+2 more
5 metrics
Option grant size
32,000 shares
Stock Option (right to buy) granted to director
Exercise price
$1.40 per share
Conversion or exercise price of stock options
Shares after transaction
32,000 options
Total derivative securities following transaction
Expiration date
June 14, 2036
Option expiration for stock option grant
Vesting period
12 monthly installments
Over 12 months following June 15, 2026
Key Terms
Stock Option (right to buy), Common Stock, vest, board of directors
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest financial
"The stock option shall vest in substantially equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
board of directors financial
"subject to the reporting person's continuing service on the issuer's board of directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What did Boundless Bio (BOLD) director Nancy Whiting report on this Form 4?
Nancy Whiting reported receiving a grant of stock options for 32,000 shares of Boundless Bio Common Stock. These options were granted as compensation for board service and give her the right to buy shares at a fixed $1.40 exercise price before expiration.
What is the exercise price and expiration date of Nancy Whiting’s Boundless Bio options?
The stock options have an exercise price of $1.40 per share and expire on June 14, 2036. Whiting may exercise vested options any time before that expiration date, subject to the plan and any applicable company policies.
How do the Boundless Bio (BOLD) stock options granted to Nancy Whiting vest?
The options vest in substantially equal monthly installments over the 12 months following June 15, 2026. If Boundless Bio holds its next annual stockholder meeting before June 15, 2027, any remaining unvested portion vests on that meeting date, assuming continued board service.